Isoniazid: all 94 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With TuberculosisRecruitingNCT07708779Phase 1
- Re-evaluating the Duration in Children of TB TreatmentNot yet recruitingNCT07656012Phase 2
- Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)Not yet recruitingNCT07163143Phase 3
- Safety of Administering Isoniazid to SLE Patients to Prevent TBRecruitingNCT06618573Phase 2/3
- A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)RecruitingNCT06022146Phase 3
- Intensified Short Course Regimen for TBM in AdultsNot yet recruitingNCT05917340Phase 3
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 2
- Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous MeningitisRecruitingNCT05383742Phase 2
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney DiseaseNot yet recruitingNCT05021731Phase 4
- Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes MellitusRecruitingNCT04600167Phase 3
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary TuberculosisActive, not recruitingNCT06058299Phase 2Results posted
- Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With TuberculosisTerminatedNCT06041919Phase 2Results posted
- Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary TuberculosisTerminatedNCT05971602Phase 2Results posted
- Phase I Open Label BCG Clinical Trial Assessing TB Drugs and VaccinesCompletedNCT05592223Phase 1Results posted
- Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis PreventionCompletedNCT05413551Phase 1Results posted
- Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary TuberculosisCompletedNCT05382312Phase 2Results posted
- A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and RifabutinCompletedNCT03891901Phase 2Results posted
- Doravirine, Rifapentine and Isoniazid InteractionCompletedNCT03886701Phase 1Results posted
- Tuberculosis Clinical Trials Consortium Study 35CompletedNCT03730181Phase 1/2Results posted
- Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)CompletedNCT03510468Phase 1Results posted
- Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)CompletedNCT03302299Phase 4Results posted
- Using Biomarkers to Predict TB Treatment DurationCompletedNCT02821832Phase 2Results posted
- Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum WomenCompletedNCT02651259Phase 1/2Results posted
- Infant TB Infection Prevention StudyCompletedNCT02613169Phase 2Results posted
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT02409290Phase 3Results posted
- High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)CompletedNCT01936831Phase 2Results posted
- Essentiality of INH in TB TherapyCompletedNCT01589497Phase 2Results posted
- Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaTerminatedNCT01550705Not applicableResults posted
- Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant WomenCompletedNCT01494038Phase 4Results posted
- REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentCompletedNCT01380080Phase 4Results posted
- Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisCompletedNCT00864383Phase 3Results posted
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary TuberculosisTerminatedNCT00728507Phase 2Results posted
- Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaCompletedNCT00164281Phase 4Results posted
- Tuberculosis Treatment Shortening TrialCompletedNCT00130247Phase 3Results posted
- Treatment of Latent TB Infection for Jailed PersonsCompletedNCT00128206Phase 3Results posted
- Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIVTerminatedNCT00080119Phase 2/3Results posted
- Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis InfectionCompletedNCT00023452Phase 3Results posted
- Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation RecipientsCompletedNCT06512831Not applicable
- An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAMCompletedNCT05994742Phase 3
- The Prophylaxis of Tuberculosis According to TSPOT Results After Kidney TransplantationStatus unknownNCT05249699Not applicable
- Pharmacogenetics-guided Isoniazid Dosing in TB-HIVStatus unknownNCT05124678Phase 2
- Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIVActive, not recruitingNCT05122026Phase 1/2
- Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated TuberculosisActive, not recruitingNCT04951986Phase 3
- Impact of LTBI Treatment on Glucose Tolerance and Chronic InflammationCompletedNCT04830462Phase 4
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and PyrazinamideSuspendedNCT04694586Phase 2
- Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital TuberculosisStatus unknownNCT04528277Phase 3
- Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device InsertionStatus unknownNCT04505943Not applicable
- Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile PatientsCompletedNCT04500522Phase 4
- Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office HysteroscopyStatus unknownNCT04500496Not applicable
- Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to HysterosalpingographyCompletedNCT04500470Not applicable
- Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine SystemCompletedNCT04500028Phase 4
- Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device InsertionCompletedNCT04500015Phase 4
- Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed AbortionStatus unknownNCT04500002Not applicable
- Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device InsertionCompletedNCT04499989Phase 4
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTBStatus unknownNCT04187469Not applicable
- Risk of SDRs Under 3HP and 1HP Regimen for LTBICompletedNCT04094012Phase 3
- Optimizing Antituberculosis Therapy in Adults With Tuberculous MeningitisStatus unknownNCT03787940Not applicable
- A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism StatusCompletedNCT03665402Not applicable
- Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsActive, not recruitingNCT03568383Phase 3
- Evaluation of Diabetes Control and Effect on Transmission and Development of TuberculosisWithdrawnNCT03498534Phase 4
- Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)CompletedNCT03278483Phase 4
- Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive IndividualsCompletedNCT02980016Phase 3
- Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy VolunteersCompletedNCT02771249Phase 1
- The Correlate of Risk Targeted Intervention StudyStatus unknownNCT02735590Phase 2/3
- Pharmacologic Response and Safety of Inhaled Insulin in Type 1 DiabetesCompletedNCT02713841Phase 1/2
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal TuberculosisStatus unknownNCT02477852Phase 4
- PK Study of Anti-TB DrugsCompletedNCT02457208Phase 1
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant TuberculosisCompletedNCT02454205Phase 2/3
- Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis PreventionCompletedNCT02430259Phase 3
- Brief Bactericidal Activity of Anti-Tuberculosis DrugsCompletedNCT02236078Phase 1
- NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced HepatitisStatus unknownNCT02076685Not applicable
- Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)Status unknownNCT01875952Phase 4
- Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyCompletedNCT01825031Phase 3
- Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesStatus unknownNCT01782950Phase 4
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- Study of Pre-clearance of Latent Tuberculosis Infection And BCG RevaccinationCompletedNCT01119521Phase 1
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectivenessCompletedNCT00931736Phase 3
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedNCT00816426Phase 1
- NAT2 in Re-challenge of INH in Patients With HepatitisStatus unknownNCT00728546Phase 4
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)TerminatedNCT00571753Phase 3
- High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant TuberculosisCompletedNCT00513396Phase 2/3
- Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected PersonsCompletedNCT00463086Not applicable
- Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis InfectionTerminatedNCT00397709Phase 4
- Preventive Therapy for Tuberculosis in HIV Infected PersonsCompletedNCT00351702Phase 3
- Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected ChildrenCompletedNCT00330304Phase 3
- Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)CompletedNCT00298870Phase 4
- Treatment of Latent Tuberculosis Infection With IsoniazidCompletedNCT00293228Phase 4
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)CompletedNCT00170209Phase 3
- A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case ContactsCompletedNCT00130325Not applicable
- TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TBCompletedNCT00023348Phase 2/3
- TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of TuberculosisCompletedNCT00023335Phase 3
- Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug UsersStatus unknownNCT00004740Not applicable
- A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and LevofloxacinCompletedNCT00000778Phase 1